comparemela.com

Carolina Urologic Research Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pluvicto May Slow Progression Earlier in Advanced Prostate Cancer

Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.

United statesDana farber cancer instituteXiaox weiDrug administrationAmerican urological association annual meetingCarolina urologic research centerNeal shore

Erleada, ADT One-Two Punch in Prostate Cancer Treatment

The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer.

United statesCarolina urologic research centerNational cancer instituteAmerican urological association annual meetingDrug administrationNational cancerUrological association annual meetingNeal shoreCarolina urologic research

Advancements in Bladder Cancer Treatment Require Multidisciplinary Team Care

Evolving treatment for bladder cancer is going to require a multidisciplinary team to ensure patients are receiving optimal care, said Neal D. Shore, MD, FACS, medical director of the Carolina Urologic Research Center.

Carolina urologic research centerCarolina urologic researchNorth starBladder cancer

Dr Shore on the Importance of a Multidisciplinary Team in Urologic Oncology

Neal Shore, MD, FACS, discusses the importance of a multidisciplinary team in light of recent developments in urologic oncology.

Carolina urologic research centerNeal shoreMedical officerGenesiscare united statesAtlantic urology clinicsBacillus calmetteUrothelial cancerMultidisciplinary careEnfortumab vedotin ejfv padcevCheckmate 901V 302 keynote a39 nct04223856

Dr Shore on Key Clinical Trial Data in Biochemically Recurrent Prostate Cancer

Neal Shore, MD, FACS, discusses findings from clinical trials in patients with prostate cancer who experience biochemical recurrence.

Carolina urologic research centerNeal shoreMedical officerGenesiscare united statesAtlantic urologyBiochemical recurrenceProstate cancerPhase 3 embark trial nct02319837

vimarsana © 2020. All Rights Reserved.